(Q37763504)

22 August 2017

1 reference

title

Systemic amyloidosis: a challenge for the rheumatologist (English)

1 reference

22 August 2017

1 reference

Marco Matucci-Cerinic

6

object named as

Marco Matucci-Cerinic

0 references

author name string

Federico Perfetto

1

1 reference

22 August 2017

Alberto Moggi-Pignone

2

1 reference

22 August 2017

Riccardo Livi

3

1 reference

22 August 2017

Alessio Tempestini

4

1 reference

22 August 2017

Franco Bergesio

5

1 reference

22 August 2017

language of work or name

English

0 references

publication date

8 June 2010

1 reference

Nature Reviews Rheumatology

22 August 2017

1 reference

22 August 2017

6

1 reference

22 August 2017

7

1 reference

22 August 2017

417-429

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2010.84

22 August 2017

0 references

cites work

Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Amyloid goiter and arthritides after kidney transplantation in a patient with systemic amyloidosis and Muckle-Wells syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

The Successful Treatment of Primary Amyloidosis with Intermittent Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Review: history of the amyloid fibril

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Restrictive Cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Bilateral carpal tunnel syndrome as a clue for the diagnosis of systemic amyloidosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Shoulder-pad sign of amyloidosis: structure of an Ig kappa III protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Jaw claudication in primary systemic amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Giant cell arteritis and secondary amyloidosis: the natural history

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Sicca syndrome as an initial symptom of amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Amyloid myopathy: an underdiagnosed entity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Myopathy in primary systemic amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Early sarcolemmal dysfunction in skeletal muscle amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Amyloid myopathy: characteristic features of a still underdiagnosed disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

The mortality and causes of death of patients with "hypergamma type" of ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Mortality in early "sawtooth" treated rheumatoid arthritis patients during the first 8-14 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Where has secondary amyloid gone?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Amyloid disease of the liver. Correlation of clinical, functional and morphologic features in forty-seven patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

A clinical analysis of the course and prognosis of forty-two patients with amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Presentation, survival and prognostic markers in AA amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Natural history and outcome in systemic AA amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Current clinical and pathogenetic understanding of beta2-m amyloidosis in long-term haemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Dialysis-related amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Pathologic fractures associated with idiopathic amyloidosis of bone in chronic hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Beta-2 microglobulin is an amyloidogenic protein in man.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Synovial-fluid beta 2-microglobulin levels in dialysis arthropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

The role of the synovium and cartilage in the pathogenesis of beta(2)-microglobulin amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Unsuitable value of abdominal fat tissue aspirate examination for the diagnosis of amyloidosis in long-term hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Diagnostic and treatment concerns in familial Mediterranean fever

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Unsuspected systemic amyloidosis diagnosed by fine-needle aspiration of the salivary gland: case report.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Labial salivary gland biopsy is a reliable test for the diagnosis of primary and secondary amyloidosis. A prospective clinical and immunohistologic study in 59 patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Rectal biopsy for the diagnosis of amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Value of rectal biopsy in the diagnosis of primary systemic amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Sporadic Cases of Hereditary Systemic Amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

The classification of amyloid deposits in clinicopathological practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

31 March 2020

The systemic amyloidoses

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Molecular mechanisms of amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Autologous stem cell transplantation for primary systemic amyloidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Resolution of amyloidosis and plasma-cell dyscrasia with combination chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Eprodisate for the treatment of renal disease in AA amyloidosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Beta-2 microglobulin in ESRD: an in-depth review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Alternative conformations of amyloidogenic proteins govern their behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Prevention of transthyretin amyloid disease by changing protein misfolding energetics.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.84

Clinical outcome and survival of secondary (AA) amyloidosis.

31 March 2020

1 reference

12 December 2020

Fine-needle aspiration biopsy from subcutaneous fat. An easy way to diagnose secondary amyloidosis

1 reference

12 December 2020

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

1 reference

12 December 2020

Secondary amyloidosis associated with giant cell arteritis/polymyalgia rheumatica

1 reference

12 December 2020

Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.

1 reference

12 December 2020

Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations

1 reference

12 December 2020

Jaw claudication in primary amyloidosis: unusual presentation of a rare disease

1 reference

12 December 2020

Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value

1 reference

12 December 2020

Comparative calorimetric study of non-amyloidogenic and amyloidogenic variants of the homotetrameric protein transthyretin

1 reference

12 December 2020

Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature

1 reference

12 December 2020

Scleroderma-like changes of the hands in primary amyloidosis

1 reference

12 December 2020

Subcutaneous fat biopsy in the diagnosis of amyloidosis secondary to chronic arthritis

1 reference

12 December 2020

Cause of death in 81 autopsied patients with rheumatoid arthritis

1 reference

12 December 2020

Therapeutic approaches to familial Mediterranean fever. What do we know and where are we going to?

1 reference

12 December 2020

Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis

1 reference

12 December 2020

Secondary systemic amyloidosis: response and survival in 64 patients

1 reference

12 December 2020

Abdominal fat tissue aspirate in amyloidosis of familial Mediterranean fever

1 reference

12 December 2020

Familial Mediterranean fever (FMF)-associated amyloidosis in childhood. Clinical features, course and outcome

1 reference

12 December 2020

Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis

1 reference

12 December 2020

Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome

1 reference

12 December 2020

Historical background and clinical treatment of dialysis-related amyloidosis

1 reference

12 December 2020

Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients

1 reference

12 December 2020

Tissue distribution of dialysis amyloidosis.

1 reference

12 December 2020

Amyloid arthropathy: characterization of the amyloid protein

1 reference

12 December 2020

Clinical aspects of systemic amyloid diseases.

1 reference

12 December 2020

No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases -- data from the Finnish national registry for kidney diseases

1 reference

12 December 2020

Amyloid myopathy masquerading as polymyositis.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2010.84

1 reference

release_vncmernovrgbbcpfqqle66qj5a

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vncmernovrgbbcpfqqle66qj5a

24 November 2022

mapped directly with Wikidata item

1 reference